Thanks for your support in 2025!

Season’s greetings! As we wrap up 2025, we are proud to reflect on a year of meaningful progress for the LaRDR.

We have enrolled over 1300 patients in 2025, providing us with extremely invaluable information for research.

Our investigators published 5 manuscripts reporting on real-world data related to our patient populations in Australia and New Zealand. We also hosted a successful hybrid Breakfast Meeting with our partners, Lymphoma Australia and Australasian Lymphoma Alliance, discussing our work and collaborations on lymphoma research.

We look forward to more achievements and stronger evidence to improve outcomes of patients living with lymphoma in 2026.